Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Guidelines Proposed For Live-Case Demonstrations

This article was originally published in The Gray Sheet

Executive Summary

Prominent interventional cardiologists plan to create guidelines for live case demonstrations that are broadcast at professional meetings in the face of intensifying scrutiny on the practice

You may also be interested in...



Live Transmission Of TAVR Found Safe, And More From Annual SCAI Conference

Interventional cardiologists presented new data at the annual meeting of The Society for Cardiovascular Angiography and Interventions supporting the safe use of live video transmission of transcatheter aortic valve replacement cases, and results from other late-breaking clinical trials.

Live Case Demos: Guideline Development Is On Track – SCAI’s Dehmer

Development of guidelines for the presentation of live case demonstrations at medical meetings is generating "very positive" feedback from FDA, according to Greg Dehmer, M.D., one of the physicians leading the project

Live Case Demos: Guideline Development Is On Track – SCAI’s Dehmer

Development of guidelines for the presentation of live case demonstrations at medical meetings is generating "very positive" feedback from FDA, according to Greg Dehmer, M.D., one of the physicians leading the project

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel